Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ABBV | AbbVie, Inc. | 0.42% | 91.00 | 1.9% | $1171.89m | |
| JNJ | Johnson & Johnson | 0.98% | 145.97 | 0.7% | $1065.86m | |
| BMY | Bristol-Myers Squibb Co. | 0.23% | 60.46 | 1.0% | $969.39m | |
| MRK | Merck & Co., Inc. | 0.44% | 77.60 | 0.7% | $838.04m | |
| PFE | Pfizer Inc. | 0.67% | 37.75 | 0.9% | $837.20m | |
| LLY | Eli Lilly & Co. | 1.24% | 149.78 | 1.1% | $429.04m | |
| AZN | AstraZeneca Plc | -1.34% | 52.40 | 1.2% | $250.76m | |
| NVS | Novartis AG | -0.89% | 84.29 | 0.2% | $155.38m | |
| GSK | GlaxoSmithKline Plc | -0.27% | 40.63 | 0.2% | $136.94m | |
| NVO | Novo Nordisk A/S | -0.82% | 62.88 | 0.1% | $84.93m | |
| SNY | Sanofi | -1.21% | 46.70 | 0.2% | $78.59m | |
| RGEN | Repligen Corp. | -4.42% | 133.35 | 7.1% | $69.88m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | -6.81% | 54.30 | 0.0% | $55.02m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 2.78% | 60.00 | 0.0% | $45.76m | |
| RETA | Reata Pharmaceuticals, Inc. | -1.40% | 157.76 | 3.4% | $37.79m |
Company Profile
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo on March 15, 2019 and is headquartered in Princeton, NJ.